{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,22]],"date-time":"2026-11-22T03:46:31Z","timestamp":1795319191551,"version":"4.10.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"General Directorate of Science and Research from Government of Valencia","award":["CIGE\/2023\/183"],"award-info":[{"award-number":["CIGE\/2023\/183"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-39607-z","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T21:46:21Z","timestamp":1770846381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Protocolized antimicrobial stewardship following filmarray pneumonia plus panel testing in mechanically ventilated patients with severe lower respiratory tract infection"],"prefix":"10.1038","volume":"16","author":[{"given":"Sof\u00eda","family":"Cano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa \u00c1ngeles","family":"Clari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliseo","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Li\u00f1an","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Olea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieves","family":"Carbonell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"issue":"5","key":"39607_CR1","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil, A. C. et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin. Infect. Dis. 63 (5), e61\u2013e111 (2016).","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"39607_CR2","doi-asserted-by":"publisher","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"A Torres","year":"2017","unstructured":"Torres, A. et al. International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European respiratory society (ERS), European society of intensive care medicine (ESICM), European society of clinical microbiology and infectious diseases (ESCMID) and asociacion Latinoamericana Del torax (ALAT). Eur. Respir J. 50 (3), 1700582 (2017).","journal-title":"Eur. Respir J."},{"issue":"6","key":"39607_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","volume":"49","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches, I. et al. ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med. 49 (6), 615\u2013632 (2023).","journal-title":"Intensive Care Med."},{"issue":"5","key":"39607_CR4","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s00134-020-05980-0","volume":"46","author":"L Papazian","year":"2020","unstructured":"Papazian, L., Klompas, M. & Luyt, C. E. Ventilator-associated pneumonia in adults: a narrative review. Intensive Care Med. 46 (5), 888\u2013906 (2020).","journal-title":"Intensive Care Med."},{"issue":"10","key":"39607_CR5","doi-asserted-by":"publisher","first-page":"e0244621","DOI":"10.1128\/jcm.02446-21","volume":"60","author":"JE Schmitz","year":"2022","unstructured":"Schmitz, J. E., Stratton, C. W., Persing, D. H. & Tang, Y. W. Forty years of molecular diagnostics for infectious diseases. J. Clin. Microbiol. 60 (10), e0244621 (2022).","journal-title":"J. Clin. Microbiol."},{"issue":"9","key":"39607_CR6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/antibiotics13090805","volume":"13","author":"IA Pintea-Simon","year":"2024","unstructured":"Pintea-Simon, I. A. et al. Rapid molecular diagnostics of pneumonia caused by Gram-Negative bacteria: A clinician\u2019s review. Antibiot. (Basel). 13 (9), 805 (2024).","journal-title":"Antibiot. (Basel)"},{"issue":"6","key":"39607_CR7","first-page":"101300","volume":"42","author":"AC Moy","year":"2023","unstructured":"Moy, A. C. et al. Performance evaluation of a PCR panel (FilmArray\u00ae pneumonia Plus) for detection of respiratory bacterial pathogens in respiratory specimens: A systematic review and meta-analysis. Anaesth. Crit. Care Pain Med. 42 (6), 101300 (2023).","journal-title":"Anaesth. Crit. Care Pain Med."},{"issue":"7","key":"39607_CR8","doi-asserted-by":"publisher","first-page":"e00128","DOI":"10.1128\/JCM.00128-20","volume":"58","author":"CN Murphy","year":"2020","unstructured":"Murphy, C. N. et al. Multicenter evaluation of the biofire filmarray Pneumonia\/Pneumonia plus panel for detection and quantification of agents of lower respiratory tract infection. J. Clin. Microbiol. 58 (7), e00128\u2013e00120 (2020).","journal-title":"J. Clin. Microbiol."},{"issue":"7","key":"39607_CR9","doi-asserted-by":"publisher","first-page":"e00135","DOI":"10.1128\/JCM.00135-20","volume":"58","author":"BW Buchan","year":"2020","unstructured":"Buchan, B. W. et al. Practical comparison of the biofire filmarray pneumonia panel to routine diagnostic methods and potential impact on antimicrobial stewardship in adult hospitalized patients with lower respiratory tract infections. J. Clin. Microbiol. 58 (7), e00135\u2013e00120 (2020).","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"39607_CR10","doi-asserted-by":"publisher","first-page":"e0069521","DOI":"10.1128\/Spectrum.00695-21","volume":"9","author":"B Posteraro","year":"2021","unstructured":"Posteraro, B. et al. Diagnosis and treatment of bacterial pneumonia in critically ill patients with COVID-19 using a multiplex PCR assay: A large Italian hospital\u2019s Five-Month experience. Microbiol. Spectr. 9 (3), e0069521 (2021).","journal-title":"Microbiol. Spectr."},{"issue":"5","key":"39607_CR11","doi-asserted-by":"publisher","first-page":"e0161622","DOI":"10.1128\/spectrum.01616-22","volume":"10","author":"D Stafylaki","year":"2022","unstructured":"Stafylaki, D. et al. Impact of molecular syndromic diagnosis of severe pneumonia in the management of critically ill patients. Microbiol. Spectr. 10 (5), e0161622 (2022).","journal-title":"Microbiol. Spectr."},{"issue":"2","key":"39607_CR12","doi-asserted-by":"publisher","first-page":"115847","DOI":"10.1016\/j.diagmicrobio.2022.115847","volume":"105","author":"J Ferrer","year":"2023","unstructured":"Ferrer, J. et al. The Biofire\u00ae Filmarray\u00ae pneumonia plus panel for management of lower respiratory tract infection in mechanically-ventilated patients in the COVID-19 era: a diagnostic and cost-benefit evaluation. Diagn. Microbiol. Infect. Dis. 105 (2), 115847 (2023).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"6","key":"39607_CR13","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jinf.2022.09.003","volume":"85","author":"S Poole","year":"2022","unstructured":"Poole, S. et al. Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: results of a randomised controlled trial. J. Infect. 85 (6), 625\u2013633 (2022).","journal-title":"J. Infect."},{"issue":"3","key":"39607_CR14","doi-asserted-by":"publisher","first-page":"e240830","DOI":"10.1001\/jamanetworkopen.2024.0830","volume":"7","author":"DL Markussen","year":"2024","unstructured":"Markussen, D. L. et al. Diagnostic stewardship in Community-Acquired pneumonia with syndromic molecular testing: A randomized clinical trial. JAMA Netw. Open. 7 (3), e240830 (2024).","journal-title":"JAMA Netw. Open."},{"issue":"12","key":"39607_CR15","doi-asserted-by":"publisher","first-page":"100928","DOI":"10.1016\/S2666-5247(24)00170-8","volume":"5","author":"A Virk","year":"2024","unstructured":"Virk, A. et al. Rapid multiplex PCR panel for pneumonia in hospitalised patients with suspected pneumonia in the USA: a single-centre, open-label, pragmatic, randomised controlled trial. Lancet. Microbe. 5(12), 100928 (2024).","journal-title":"Lancet. Microbe."},{"issue":"1","key":"39607_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/antibiotics13010067","volume":"13","author":"A Verroken","year":"2024","unstructured":"Verroken, A. et al. Optimized antibiotic management of critically ill patients with severe pneumonia following multiplex polymerase chain reaction testing: A prospective clinical exploratory trial. Antibiot. (Basel). 13 (1), 67 (2024).","journal-title":"Antibiot. (Basel)"},{"issue":"1","key":"39607_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13054-022-04006-z","volume":"26","author":"FJ Molina","year":"2020","unstructured":"Molina, F. J. et al. Diagnostic concordance between BioFire\u00ae FilmArray\u00ae Pneumonia Panel and culture in patients with COVID-19 pneumonia admitted to intensive care units: the experience of the third wave in eight hospitals in Colombia. Crit. Care 26(1), 130 (2020).","journal-title":"Crit. Care"},{"issue":"1","key":"39607_CR18","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1017\/ash.2022.358","volume":"3","author":"JN Esplund","year":"2023","unstructured":"Esplund, J. N. et al. Clinical impact of a multiplex rapid diagnostic pneumonia panel in critically ill patients. Antimicrob. Steward Healthc. Epidemiol. 3 (1), e5 (2023).","journal-title":"Antimicrob. Steward Healthc. Epidemiol."},{"issue":"1","key":"39607_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13613-024-01348-5","volume":"4","author":"P Bay","year":"2024","unstructured":"Bay, P. et al. Performance and impact of rapid multiplex PCR on diagnosis and treatment of ventilated hospital-acquired pneumonia in patients with extended-spectrum \u03b2-lactamase-producing enterobacterales rectal carriage. Ann. Intensive Care. 4 (1), 118 (2024).","journal-title":"Ann. Intensive Care"},{"issue":"9","key":"39607_CR20","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.cmi.2020.11.014","volume":"27","author":"N Gastli","year":"2021","unstructured":"Gastli, N. et al. Multicentric evaluation of biofire filmarray pneumonia panel for rapid bacteriological Documentation of pneumonia. Clin. Microbiol. Infect. 27 (9), 1308\u20131314 (2021).","journal-title":"Clin. Microbiol. Infect."},{"issue":"12","key":"39607_CR21","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.3390\/biomedicines11123330","volume":"11","author":"A Rodr\u00edguez","year":"2023","unstructured":"Rodr\u00edguez, A. et al. Clinical and microbiological impact of implementing a decision support algorithm through microbiologic rapid diagnosis in critically ill patients: an epidemiological retrospective Pre-\/Post-Intervention study. Biomedicines 11 (12), 3330 (2023).","journal-title":"Biomedicines"},{"issue":"10","key":"39607_CR22","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s10096-021-04213-6","volume":"40","author":"N Maataoui","year":"2021","unstructured":"Maataoui, N. et al. Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit. Eur. J. Clin. Microbiol. Infect. Dis. 40 (10), 2227\u20132234 (2021).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"1","key":"39607_CR23","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s13054-020-03114-y","volume":"24","author":"C Monard","year":"2020","unstructured":"Monard, C. et al. Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia. Crit. Care. 24 (1), 434 (2020).","journal-title":"Crit. Care"},{"key":"39607_CR24","doi-asserted-by":"publisher","first-page":"804611","DOI":"10.3389\/fcimb.2022.804611","volume":"12","author":"F Guillotin","year":"2022","unstructured":"Guillotin, F. et al. Potential impact of rapid multiplex PCR on antimicrobial therapy guidance for ventilated Hospital-Acquired pneumonia in critically ill Patients, A prospective observational clinical and economic study. Front. Cell. Infect. Microbiol. 12, 804611 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"39607_CR25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/23744235.2020.1866774","volume":"53","author":"D Furukawa","year":"2021","unstructured":"Furukawa, D., Kim, B. & Jeng, A. Real-life utilization of BioFire\u00ae Filmarray\u00ae pneumonia panel as an antibiotic stewardship tool. Infect. Dis. (Lond). 53 (4), 308\u2013313 (2021).","journal-title":"Infect. Dis. (Lond)"},{"issue":"8","key":"39607_CR26","doi-asserted-by":"publisher","first-page":"ofad382","DOI":"10.1093\/ofid\/ofad382","volume":"10","author":"MM Miller","year":"2023","unstructured":"Miller, M. M. et al. Implementation of a rapid multiplex polymerase chain reaction pneumonia panel and subsequent antibiotic De-escalation. Open. Forum Infect. Dis. 10 (8), ofad382 (2023).","journal-title":"Open. Forum Infect. Dis."},{"issue":"4","key":"39607_CR27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jmii.2024.06.004","volume":"57","author":"HY Chen","year":"2024","unstructured":"Chen, H. Y. et al. The real-world impact of the biofire filmarray blood culture identification 2 panel on antimicrobial stewardship among patients with bloodstream infections in intensive care units with a high burden of drug-resistant pathogens. J. Microbiol. Immunol. Infect. 57 (4), 580\u2013593 (2024).","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"8","key":"39607_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.eimc.2023.04.006","volume":"41","author":"M\u00c1 Clari","year":"2023","unstructured":"Clari, M. \u00c1., Carbonell, N., Albert, E. & Navarro, D. Proposal for antimicrobial therapy stewardship of lower respiratory tract infection in mechanically-ventilated patients based upon the Biofire\u00ae Filmarray\u00ae pneumonia plus panel results. Enferm Infecc Microbiol. Clin. (Engl Ed). 41 (8), 521\u2013523 (2023).","journal-title":"Enferm Infecc Microbiol. Clin. (Engl Ed)"},{"key":"39607_CR29","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.enfi.2022.05.005","volume":"33","author":"S Arias-Rivera","year":"2022","unstructured":"Arias-Rivera, S., Jam-Gatell, R., Nuvials-Casals, X., V\u00e1zquez-Calatayud, M. & equipo Neumon\u00eda Zero. Update of the recommendations of the pneumonia zero project. Enferm Intensiva. 33, S17\u2013S30 (2022).","journal-title":"Enferm Intensiva"},{"issue":"2","key":"39607_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/CCM.0000000000002736","volume":"46","author":"F \u00c1lvarez-Lerma","year":"2018","unstructured":"\u00c1lvarez-Lerma, F. et al. Prevention of Ventilator-Associated pneumonia: the multimodal approach of the Spanish ICU pneumonia zero program. Crit. Care Med. 46 (2), 181\u2013188 (2018).","journal-title":"Crit. Care Med."},{"issue":"4","key":"39607_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.medin.2022.12.002","volume":"47","author":"F \u00c1lvarez-Lerma","year":"2023","unstructured":"\u00c1lvarez-Lerma, F. et al. Impact of the zero resistance program on acquisition of multidrug-resistant bacteria in patients admitted to intensive care units in Spain. A prospective, intervention, multimodal, multicenter study. Med. Intensiva (Engl Ed). 47 (4), 193\u2013202 (2023).","journal-title":"Med. Intensiva (Engl Ed)"},{"issue":"1","key":"39607_CR32","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13054-015-0800-5","volume":"19","author":"JG Montero","year":"2015","unstructured":"Montero, J. G. et al. Combatting resistance in intensive care: the multimodal approach of the Spanish ICU zero resistance program. Crit. Care. 19 (1), 114 (2015).","journal-title":"Crit. Care"},{"key":"39607_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-024-04967-9","author":"S Cano","year":"2024","unstructured":"Cano, S. et al. Impact of the microscopic quality of endotracheal aspirates on the performance of the Filmarray\u00ae pneumonia plus panel in intensive care unit patients with suspected lower respiratory tract infection. Eur. J. Clin. Microbiol. Infect. Dis. Oct. https:\/\/doi.org\/10.1007\/s10096-024-04967-9 (2024).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis. Oct."},{"key":"39607_CR34","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0025-6196(25)09678-8","volume":"50","author":"PR Murray","year":"1975","unstructured":"Murray, P. R. et al. Microscopic and bacteriologic analysis of sputum. Mayo Clin. Proc. 50, 339\u2013344 (1975).","journal-title":"Mayo Clin. Proc."},{"key":"39607_CR35","doi-asserted-by":"crossref","unstructured":"Drummond, M. F., Sculpher, M. J., Torrance, G. W., O'Brien, B. J., Stoddart, G. L. Cost-effectiveness analysis. In: Methods for the Economic Evaluation of Health Care Programmes, 3rd Edition (Oxford University Press, 2005).","DOI":"10.1093\/oso\/9780198529446.003.0005"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39607-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39607-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39607-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:34:55Z","timestamp":1772800495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39607-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39607"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39607-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MAC, NC and DN received conference and advisory fees from bioMerieux. The rest of the authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The current study was approved by the Institutional Review Board (IRB) Research Ethics Committee of Hospital Cl\u00ednico Universitario INCLIVA (2023\/182). A waiver of informed consent documentation was issued by the IRB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"8338"}}